Cancer gene panel of plasma DNA in patients with solid tumor

Cancer gene panel of plasma DNA in patients with solid tumor - Cancer gene panel of plasma DNA in patients with solid tumor

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000040506

Enrollment

Registered

2020-05-26

Start date

2020-05-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solid tumor

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patinets with metastatic solic tumor 2) Age >= 20 years old 3) Patients with tumor harboring gene alteration 4) Written informed consent

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Detection rate of somatic gene alterations in plasma DNA	—

Secondary

Measure	Time frame
Detection rate of somatic gene alterations in plasma DNA by cancer type. Detection rate of somatic gene alterations in plasma DNA by gene.	—

Countries

Japan

Contacts

Public ContactHirotsugu Kenmotsu

Shizuoka Cancer Center Division of Genetic Medicine Promotion

h.kenmotsu@scchr.jp0559895222

Outcome results